Europe Embolization Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The Europe embolization devices market is projected to grow significantly, reaching approximately US$ 1,671.99 million by 2031, up from US$ 886.97 million in 2024, with an estimated compound annual growth rate (CAGR) of 9.6% from 2025 to 2031. This growth is primarily driven by the increasing incidence of colorectal cancer and gastrointestinal bleeding across the region.

Market Overview and Segmentation

The market is divided into several key regions, including Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany is expected to dominate the market due to its robust healthcare infrastructure and high rates of medical technology adoption. The market is segmented by type, application, and end user:

1. Type: The embolization devices market includes embolization coils, plugs, beads, glues, and other devices. In 2024, embolization coils are anticipated to hold the largest market share, with further segmentation into central and peripheral applications.

2. Application: The market is categorized into neurology, peripheral vascular disease, oncology, urology, and others. Neurology is expected to lead the market in 2024.

3. End User: The end users of embolization devices include hospitals, ambulatory centers, and others, with hospitals accounting for the largest share in 2024.

Market Dynamics

The growth of the embolization devices market in Europe is significantly influenced by the rising prevalence of conditions requiring embolization, such as colorectal cancer. The increasing number of interventional procedures and advancements in medical technology are also contributing to market expansion. Companies in this sector are focusing on geographic expansion, product innovation, and technological advancements to enhance their market presence.

Recent Developments

Several notable product launches and approvals are expected to propel market growth:

In January 2024, Zylox-Tonbridge Medical Technology Co Ltd received marketing approval for the ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System. This device is designed for minimally invasive treatment of peripheral arterial embolism and has applications in managing visceral aneurysms and endoleaks from abdominal aortic aneurysms.
In October 2023, Sirtex Medical launched the Lava Liquid Embolic System (LES), which is approved for treating peripheral vascular hemorrhage. This system offers customizable volume and viscosity options, allowing for precise occlusion of target vessels, particularly in challenging anatomical locations.

Country Insights

Germany is the leading country in the European embolization devices market, driven by a strong healthcare system, substantial investments in medical research, and early adoption of minimally invasive technologies. According to GLOBOCAN 2022, Germany reported around 62,544 new colorectal cancer cases in 2022, highlighting the need for effective treatment options. The country's hospitals are well-equipped for interventional radiology, frequently employing embolization techniques for various conditions, including tumors and vascular malformations.

Germany's healthcare sector benefits from a supportive reimbursement framework that encourages the adoption of innovative procedures. Additionally, the presence of leading academic institutions and research centers fosters collaboration with MedTech companies to advance embolization technologies. For instance, a research team from Charite - University Hospital Berlin received recognition for their study on genicular artery embolization for knee osteoarthritis, showcasing the potential of embolization in diverse medical applications.

Competitive Landscape

Key players in the embolization devices market include Medtronic Plc, Cook Medical Holdings LLC, Stryker Corp, Boston Scientific Corp, Terumo Corp, Johnson & Johnson, Abbott Laboratories, and others. These companies are actively pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

In conclusion, the Europe embolization devices market is poised for substantial growth, driven by increasing disease prevalence, technological advancements, and strategic initiatives by key players. The focus on innovative treatment options and the expansion of healthcare infrastructure will further support market development in the coming years.

Product Code: BMIRE00032147

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Europe Embolization Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Pricing Analysis
- 4.3.1 Pricing Analysis by Key Brands

5. Europe Embolization Devices Market - Key Market Dynamics

5.1 Europe Embolization Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Clinical Conditions
- 5.2.2 Burgeoning Demand for Minimally Invasive Techniques
5.3 Market Restraints
- 5.3.1 Complications Arising During or After Embolization
5.4 Market Opportunities
- 5.4.1 New Product Developments and Marketing Approvals
5.5 Future Trends
- 5.5.1 Transforming Embolization Through Clinical Innovation
5.6 Impact of Drivers and Restraints:

6. Embolization Devices Market - Europe Analysis

6.1 Europe Embolization Devices Market Revenue (US$ Million), 2021-2031
6.2 Europe Embolization Devices Market Forecast Analysis

7. Europe Embolization Devices Market Analysis - by Product Type

7.1 Embolization Coils
- 7.1.1 Overview
- 7.1.2 Embolization Coils: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Plugs
- 7.2.1 Overview
- 7.2.2 Plugs: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Beads
- 7.3.1 Overview
- 7.3.2 Beads: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Glues
- 7.4.1 Overview
- 7.4.2 Glues: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Embolization Devices Market Analysis - by Application

8.1 Neurology
- 8.1.1 Overview
- 8.1.2 Neurology: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Peripheral Vascular Disease
- 8.2.1 Overview
- 8.2.2 Peripheral Vascular Disease: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Oncology
- 8.3.1 Overview
- 8.3.2 Oncology: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Urology
- 8.4.1 Overview
- 8.4.2 Urology: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Embolization Devices Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Ambulatory Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Centers: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Embolization Devices Market - Country Analysis

10.1 Europe
- 10.1.1 Europe Embolization Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 Europe Embolization Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 Germany: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 Germany: Europe Embolization Devices Market Share - by Product Type
    - 10.1.1.2.2 Germany: Europe Embolization Devices Market Share - by Embolization Coils
    - 10.1.1.2.3 Germany: Europe Embolization Devices Market Share - by Application
    - 10.1.1.2.4 Germany: Europe Embolization Devices Market Share - by End User
  - 10.1.1.3 United Kingdom: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 United Kingdom: Europe Embolization Devices Market Share - by Product Type
    - 10.1.1.3.2 United Kingdom: Europe Embolization Devices Market Share - by Embolization Coils
    - 10.1.1.3.3 United Kingdom: Europe Embolization Devices Market Share - by Application
    - 10.1.1.3.4 United Kingdom: Europe Embolization Devices Market Share - by End User
  - 10.1.1.4 France: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 France: Europe Embolization Devices Market Share - by Product Type
    - 10.1.1.4.2 France: Europe Embolization Devices Market Share - by Embolization Coils
    - 10.1.1.4.3 France: Europe Embolization Devices Market Share - by Application
    - 10.1.1.4.4 France: Europe Embolization Devices Market Share - by End User
  - 10.1.1.5 Italy: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.5.1 Italy: Europe Embolization Devices Market Share - by Product Type
    - 10.1.1.5.2 Italy: Europe Embolization Devices Market Share - by Embolization Coils
    - 10.1.1.5.3 Italy: Europe Embolization Devices Market Share - by Application
    - 10.1.1.5.4 Italy: Europe Embolization Devices Market Share - by End User
  - 10.1.1.6 Spain: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.6.1 Spain: Europe Embolization Devices Market Share - by Product Type
    - 10.1.1.6.2 Spain: Europe Embolization Devices Market Share - by Embolization Coils
    - 10.1.1.6.3 Spain: Europe Embolization Devices Market Share - by Application
    - 10.1.1.6.4 Spain: Europe Embolization Devices Market Share - by End User
  - 10.1.1.7 Rest of Europe: Europe Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.7.1 Rest of Europe: Europe Embolization Devices Market Share - by Product Type
    - 10.1.1.7.2 Rest of Europe: Europe Embolization Devices Market Share - by Embolization Coils
    - 10.1.1.7.3 Rest of Europe: Europe Embolization Devices Market Share - by Application
    - 10.1.1.7.4 Rest of Europe: Europe Embolization Devices Market Share - by End User

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Expansion
12.3 New Product Development and Approval
12.4 Merger and Acquisition
12.5 Partnerships and Collaboration

13. Company Profiles

13.1 Medtronic Plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Cook Medical Holdings LLC
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Stryker Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Boston Scientific Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Terumo Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Johnson & Johnson
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Abbott Laboratories
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 NeuroSafe Medical Co. Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Wallaby Medical
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Sirtex Medical Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 GEM srl
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Penumbra Inc.
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 Balt
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 Lepu Medical Technology Beijing Co Ltd
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 INVAMED
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments
13.16 Meril Life Sciences Pvt Ltd
- 13.16.1 Key Facts
- 13.16.2 Business Description
- 13.16.3 Products and Services
- 13.16.4 Financial Overview
- 13.16.5 SWOT Analysis
- 13.16.6 Key Developments
13.17 Merit Medical Systems Inc
- 13.17.1 Key Facts
- 13.17.2 Business Description
- 13.17.3 Products and Services
- 13.17.4 Financial Overview
- 13.17.5 SWOT Analysis
- 13.17.6 Key Developments
13.18 Lifetech Scientific Corp
- 13.18.1 Key Facts
- 13.18.2 Business Description
- 13.18.3 Products and Services
- 13.18.4 Financial Overview
- 13.18.5 SWOT Analysis
- 13.18.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms